45 Continued virologic and biochemical improvement through 96 weeks of entecavir treatment in HBeAg(−) chronic hepatitis B patients (study ETV-027)

Authors:
  • UAU.S. Akarca
    U.S. Akarca
  • GHG. Hatzis
    G. Hatzis
  • GKG. Kitis
    G. Kitis
  • CLC.L. Lai
    C.L. Lai
  • HCH. Cheinquer
    H. Cheinquer
  • TCT.T. Chang
    T.T. Chang
  • RZR. Zink
    R. Zink
  • JZJ. Zhu
    J. Zhu
  • HBH. Brett-Smith
    H. Brett-Smith
Publisher website
Google Scholar
Abstract
No abstract available